Should you sell your shares if they report badly?

It's reporting season, what should you do if your shares report badly?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's finally reporting season and already there has been some negative reactions to some of the reports. For example, Credit Corp Group Limited (ASX: CCP) and Navitas Limited (ASX: NVT) have fallen by 5.83% and 8.02% respectively after reporting today.

However, both shares revealed very different results. The market is reacting to the expectations of what those two companies were going to report, not specifically the numbers themselves.

Was it Credit Corp's fault for not delivering on expectations or the market's fault for expecting too much?

Either way, it can be hard knowing what to do if you own shares and they go down on report day. Perhaps the market is right and it's time to sell? Perhaps investors should just hold? Maybe the share price drop means it's now a buying opportunity?

Unless investors are planning on never selling their shares, or holding for extremely long periods of time, I think it's worth asking 'what would I do at today's price if I didn't own this share?'.

Investors can become anchored to the buying price of their shares, but the market doesn't care what price you paid – it all depends on the future of the business. If you think that your share has good prospects at today's price then it could be worth buying more. If you think the business is still overvalued and doesn't have a good future then it could be worth selling.

It also depends on your original investment thesis. I don't mind if Ramsay Health Care Limited (ASX: RHC) has one bad report because I expect it to grow steadily over many years. That's why 'ignoring the noise' can be such good advice, most investors are investing with much shorter timeframes.

Foolish takeaway

I hope reporting season is more positive than it has been so far and I hope your shares do well. I'm confident in all of the shares that I own for the long-term, so I'll be looking for any bargains if they show up.

Motley Fool contributor Tristan Harrison owns shares of Ramsay Health Care Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »